These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7434567)

  • 1. Possible immunogenetic correlations of HBeAg.
    Babeş VT; Tănase M; Tatu A
    Virologie; 1980; 31(3):241-2. PubMed ID: 7434567
    [No Abstract]   [Full Text] [Related]  

  • 2. Reaction spectrum of anti-HBe and ABO blood groups.
    Babeş VT; Tănase M; Blană D
    Virologie; 1981; 32(1):81-2. PubMed ID: 6795815
    [No Abstract]   [Full Text] [Related]  

  • 3. Reaction spectrum of anti-HBe and AB0 blood groups.
    Babeş VT; Tănase M; Blană D
    Virologie; 1981; 32(1):81-2. PubMed ID: 7052980
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 5. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular cytotoxicity against autologous hepatocytes in chronic hepatitis B--its relationship to the HBeAg/anti-HBe status.
    Poralla T; Hütteroth TH; Staritz M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Apr; 23(4):183-7. PubMed ID: 4060809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The risk of virus transmission and morbidity in sexual partners of HBeAg positive patients with chronic liver disease (author's transl)].
    Friedrich K; Henning H
    Z Gastroenterol; 1982 Jul; 20(7):405-10. PubMed ID: 7113316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.
    Imai M; Nomura M; Gotanda T; Sano T; Tachibana K; Miyamoto H; Takahashi K; Toyama S; Miyakawa Y; Mayumi M
    J Immunol; 1982 Jan; 128(1):69-72. PubMed ID: 6172494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of immunopotentiator on six patients with HBeAg positive chronic hepatitis (author's transl)].
    Kosaka Y; Tameda Y; Nishimura A; Fujimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Aug; 78(8):1675. PubMed ID: 7321268
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of HBeAg in the New York Blood Center hepatitis B vaccine.
    Vnek J; Hashimoto N; Prince AM
    Dev Biol Stand; 1983; 54():217-21. PubMed ID: 6228461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance and clinical course of chronic delta-positive hepatitis in children (comparison with chronic delta-negative hepatitis in childhood and delta-positive forms in adults)].
    Calzia R; Navone C; Ciravegna B; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C
    G Clin Med; 1984; 65(5-6):255-60. PubMed ID: 6468807
    [No Abstract]   [Full Text] [Related]  

  • 16. [HBeAg/anti-HBe system in acute viral hepatitis B].
    Gvojić B; Miling M
    Lijec Vjesn; 1985 May; 107(5):191-5. PubMed ID: 4010449
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction spectrum of HBe antibodies.
    Babeş VT; Tănase M
    Virologie; 1981; 32(1):3-7. PubMed ID: 7303490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-Cw7 and HBS Ag negative chronic active hepatitis.
    Lepage V; Degos F; Carella G; De Lima M; Giraud MC; Degos L
    Tissue Antigens; 1981 Aug; 18(2):105-7. PubMed ID: 7336418
    [No Abstract]   [Full Text] [Related]  

  • 20. A new hepatitis B vaccine containing HBeAg in addition to HBsAg.
    Prince AM; Vnek J; Stephan W
    Dev Biol Stand; 1983; 54():13-22. PubMed ID: 6228452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.